Drug factory · FDA FEI 3010401502

Apertus Pharmaceuticals, LLC

331 Consort Dr, Ballwin, MO, United States

United States: 1

Problems found, fixed voluntarily at FDA's last inspection, Oct 31, 2025.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

2 drug inspections on record since 2020: 0 with no problems, 2 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
Methenamine, Sodium Phosphate, Monobasic, Monohydrate, Phenyl Salicylate, MethylMakes it Apace Packaging 15338-502, 15338-503

FDA inspection history

EndedResultProgramProblems noted
Oct 31, 2025Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 16, 2020Problems found, fixed voluntarilyDrug Quality Assurance—

Registered with FDA for: manufacture.